Tower Research Capital LLC (Trc) Eq Rx, Inc. Transaction History

Tower Research Capital LLC (Trc)

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$1.66 - $2.31 $1,859 - $2,587	1,120 Added 17.03%	7,697 $17,000
Q2 2023 Aug 14, 2023	SELL	$1.61 - $1.96 $9,154 - $11,144	-5,686 Reduced 46.37%	6,577 $12,000
Q1 2023 May 09, 2023	SELL	$1.8 - $2.83 $9,259 - $14,557	-5,144 Reduced 29.55%	12,263 $24,000
Q4 2022 Feb 10, 2023	BUY	$2.05 - $5.5 $24,413 - $65,499	11,909 Added 216.61%	17,407 $43,000
Q3 2022 Nov 10, 2022	SELL	$0.94 - $5.99 $6,936 - $44,200	-7,379 Reduced 57.3%	5,498 $27,000
Q2 2022 Aug 15, 2022	BUY	$3.2 - $5.69 $4,934 - $8,773	1,542 Added 13.6%	12,877 $61,000
Q1 2022 May 12, 2022	BUY	$2.8 - $7.39 $31,597 - $83,396	11,285 Added 22570.0%	11,335 $47,000
Q4 2021 Feb 14, 2022	BUY	$5.92 - $9.98 $296 - $499	50 New	50 $0

67.8M

Ticker EQRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 448,140,992
Description
EQRx, Inc., a pharmaceutical company, engages in developing medicines primarily for the treatment of oncology and immune-inflammatory diseases in the United States. The company's pre-registrational programs in Phase III clinical trial include Aumolertinib, an epidermal growth factor receptor (EGFR) inhibitor for the treatment of patients with EG...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.